Skip to main content

Table 1 Indications to TAVI

From: Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review

CLINICAL INDICATIONS CLINICAL CONTRAINDICATIONS ECHOCARDIOGRAPHIC INDICATIONS ECHOCARDIOGRAPHIC CONTRAINDICATIONS
Severe AS with Symptoms
and
High Risk for Surgery
Life Expectancy < 1 Year
Severe Respiratory Insufficiency for Transapical Approach
Previous Surgery of the Left Ventricle using a Patch for Transapical Approach
Severe AS
18 < Aortic Annulus < 25 mm for SAPIEN Valve;
20 < Aortic Annulus < 27 mm for CORE Valve
Aortic Tubular Junction < 45 mm for CORE Valve
Bicuspid Aortic Valve
Subaortic Stenosis
Height of coronary ostia from the base of aortic valve leaflets < 10 mm
Asymmetric Heavy Aortic Valvular Calcification
Intracardiac Thrombus
Mitral Regurgitation > 2+
Left Ventricular Ejection Fraction < 20%
Severe Left Ventricular Hypertrophy (< 1,7 cm)
Bulky Atherosclerosis of the Ascending Aorta and Arch for Transfemoral Approach
Calcified Pericardium for Transapical Approach